Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-09-05
2006-09-05
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C549S058000
Reexamination Certificate
active
07101906
ABSTRACT:
Disclosed herein are compounds comprisingor a pharmaceutically acceptable salt or a prodrug thereof,wherein a dashed line represents the presence or absence of a bond;Y is a carboxylic acid, sulfonic acid, or phosphonic acid functional group; or an amide or ester thereof comprising from 0 to 12 carbon atoms; or Y is hydroxymethyl or an ether thereof comprising from 0 to 12 carbon atoms; or Y is a tetrazolyl functional group;A is —(CH2)6—, cis —CH2—CH═CH—(CH2)3—, or —CH2—C≡C—(CH2)3— wherein 1 or 2 carbons may be substituted with S or O;B is hydrogen, C1-6hydrocarbyl, CN, CO2H, or —(CH2)mX(CH2)pH, wherein m is at least 1 and the sum of m and p is from 1 to 5;X is S or O;J is H, CH3, or CF3;D is a covalent bond, CH2, O, or S; andE is an aromatic heterobicyclic ring system which may have substituents comprising up to 6 non-hydrogen atoms each.Methods, compositions, and medicaments related thereto are also disclosed.
REFERENCES:
patent: 4131738 (1978-12-01), Smith
patent: 4147877 (1979-04-01), Smith
patent: 4154949 (1979-05-01), Johnson et al.
patent: 4166452 (1979-09-01), Generales
patent: 4256108 (1981-03-01), Theeuwes
patent: 4265874 (1981-05-01), Bonsen et al.
patent: 5703108 (1997-12-01), Cameron et al.
patent: 6552067 (2003-04-01), Cameron et al.
patent: 6586468 (2003-07-01), Maruyama et al.
patent: 2004/0235958 (2004-11-01), Yariv et al.
patent: 2715838 (1978-10-01), None
patent: 1601994 (1978-04-01), None
patent: WO 02/092099 (2002-11-01), None
patent: WO 02/102389 (2002-12-01), None
patent: WO 03/047513 (2003-06-01), None
Chourasia and Jain in J Pharm Pharmaceut Sci 6 (1): 33-66, 2003 Remington's Pharmaceutical Sciences, Mack Publishing Company, Easton, Pa., 16th Edition, 1980.
Shareef et. al (AAPS PharmSci 2003; 5 (2) Article 17).
Burk Robert M.
Donde Yariv
Garst Michael E.
Nguyen Jeremiah H.
Allergan Inc.
Baran Robert J.
Johnson Brent A.
Nolan Jason M.
Saeed Kamal A.
LandOfFree
2,3,4-substituted cyclopentanones as therapeutic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2,3,4-substituted cyclopentanones as therapeutic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2,3,4-substituted cyclopentanones as therapeutic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3567859